hypoactive sexual desire disorder


Also found in: Thesaurus, Medical, Legal, Acronyms, Encyclopedia, Wikipedia.
Related to hypoactive sexual desire disorder: Sexual aversion disorder, HSDD

hypoactive sexual desire disorder

n.
A psychological disorder characterized by deficiencies in sexual desire that cause significant distress.
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.
References in periodicals archive ?
The global hypoactive sexual desire disorder (HSDD) treatment market is set to expand at a CAGR of 5.2% from 2019 to 2027.
Vyleesi is approved for the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD).
Role of hormones in hypoactive sexual desire disorder and current treatment.
Hypoactive sexual desire disorder in women: treatment options beyond testosterone and approaches to communicating with patients on sexual health.
Development and evaluation of the Women's Sexual Interest Diagnostic Interview (WSID): a structured interview to diagnose hypoactive sexual desire disorder (HSDD) in standardized patients.
Clayton said the causes of HSDD in the study cohort were "biologically based" but that hypoactive sexual desire disorder is a biopsychosocial condition.
In 2015, the FDA approved flibanserin (Addyi) a serotonin 1A receptor agonist and a serotonin 2A receptor antagonist, as the first treatment for hypoactive sexual desire disorder in premenopausal women.
About 40% of women experience low desire and 6%-10% meet criteria for the diagnosis of hypoactive sexual desire disorder (HSDD).
The study included 50 women diagnosed with female sexual dysfunction, which included hypoactive sexual desire disorder, female sexual arousal disorder, female orgasmic disorder, or combined genital and subjective arousal disorder.
GlobalData's clinical trial report, "Female Hypoactive Sexual Desire Disorder Global Clinical Trials Review, H2, 2015" provides an overview of Female Hypoactive Sexual Desire Disorder clinical trials scenario.
In a series of three phase III clinical trials in North America, premenopausal women who met the DSM-IV diagnostic criteria for hypoactive sexual desire disorder (HSDD) and who were in a stable monogamous relationship took flibanserin or placebo.